| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Fulcrum Therapeutics, Inc. (FULC) has 4 insiders with recent SEC Form 4 filings, including 6 buys and 0 sells. FULC is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 7.08M | $26.70M | +417.6K | |
| 10% | 6.05M | $22.82M | - | |
| Dir | 469.9K | $1.77M | - | |
| Other | 10.3K | $38.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 22, 2019 | Third Rock Ventures Iii, L.P.65 | 10% Owner | Buy | 81,250 | $16.00 | $1,300,000.00 | +1.4% | |
| Jul 22, 2019 | Casdin Capital, LLC97 | 10% Owner | Buy | 140,000 | $15.84 | $2,217,495.00 | +8.5% | |
| Jul 22, 2019 | 6 Dimensions Capital, L.P. | 10% Owner | Buy | 118,750 | $16.00 | $1,900,000.00 | +26.9% | |
| Jul 22, 2019 | Levin Mark J | Director, 10% Owner | Buy | 81,250 | $16.00 | $1,300,000.00 | +1.4% |